Brian L. Pipes
University of Arizona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Brian L. Pipes.
Transfusion | 2006
Brian L. Pipes; Tom C. Tsang; Shu Xin Peng; Roger Fiederlein; Michael Graham; David T. Harris
BACKGROUND: The establishment of donor‐derived hematopoiesis in the recipients of hematopoietic stem cell (HSC) transplants involves extensive proliferation and differentiation of HSCs. Data from long‐term survivors of HSC transplants suggest that these transplanted HSCs may experience a debilitating replicative senescence. A significant posttransplant shortening of peripheral blood mononuclear cell (PBMNC) telomeres has been observed in both marrow transplant and peripheral blood progenitor cell transplant recipients. Similar studies have not been performed for umbilical cord blood (UCB) HSC transplants, which might be expected to exhibit increased posttransplant replicative potential due to their inherently greater telomere length.
BioTechniques | 2005
Brian L. Pipes; Farha H. Vasanwala; Tom C. Tsang; Tong Zhang; Phoebe Luo; David T. Harris
1.Lin Cereghino, J. and J.M. Cregg. 2000. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev. 24:45-66. 2.Cregg, J.M., K.J. Barringer, A.Y. Hessler, and K.R. Madden. 1985. Pichia pastoris as a host system for transformations. Mol. Cell. Biol. 5:3376-3385. 3.Cregg, J.M. and K.A. Russell. 1998. Transformation methods, p. 27-39. In D.R. Higgins and J.M. Cregg (Eds.), Methods in Molecular Methods Molecular Biology, Vol. 103: Pichia Protocols. Humana Press, Totowa, NJ. 4.Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168. 5.Dohmen, R.J., A.W.M. Strasser, C.B. Honer, and C.P. Hollenberg. 1991. An efficient transformation procedure enabling long-term storage of competent cells of various yeast genera. Yeast 7:691-692.
Archive | 1994
Katherine W. Osteryoung; Brian L. Pipes; Nadja Wehmeyer; Elizabeth Vierling
Thermotolerance, or the ability of organisms to withstand exposure to potentially lethal high temperatures, is thought to be conferred by the induction of heat shock proteins (HSPs) (Lindquist 1986). Several major families of HSPs classified according to molecular weight and amino acid similarity have been defined, although how they contribute to the development of thermotolerance is not well understood. Among the HSPs most highly induced by heat stress in eukaryotes is a class of nuclear-encoded proteins ranging in size from 15 to 30 kD referred to as the small HSPs (sHSPs). Though diverse in size and primary structure, the sHSPs can be identified based on their similar hydropathy profiles and homology to the acrystallin proteins of the eye lens (Lindquist and Craig 1988).
International Journal of Hyperthermia | 2006
Pascal Dammeyer; Melba C. Jaramillo; Brian L. Pipes; Michael Badowski; Tom C. Tsang; David T. Harris
Purpose: In cytokine immunotherapy of cancer it is critical to deliver sufficiently high local cytokine concentrations in order to reach the therapeutic threshold needed for clinical efficacy. Simultaneously, for optimal clinical safety adverse effects caused by high systemic cytokine levels must be minimized. One of the most promising anti-cancer therapeutic cytokines, granulocyte-macrophage colony-stimulating factor (GM-CSF), has elicited anti-tumour immune responses in animal studies and clinical trials. However, the clinical efficacy has been limited, with local GM-CSF levels being therapeutically insufficient and systemic toxicity being a limiting factor. Methods: To address these problems we have developed a novel GM-CSF expression vector, pAD-HotAmp-GM-CSF, which can provide high levels of GM-CSF expression, and induction of cytokine expression to limited tissue areas. This expression system combines inducible and amplifying elements in a single multi-genic construct. The first transcriptional unit contains the inducible element, the heat shock protein 70B (HSP70B) promoter that regulates expression of the transcription-activating factor tat. Results: Upon the binding of tat to the second promoter, the HIV2 long terminal repeat amplifies downstream gene expression of the therapeutic cytokine GM-CSF. Moderate hyperthermia at 42°C for 30 min induced GM-CSF expression in pAD-HotAmp-GM-CSF that was over 2.5- and 2.8-fold higher than levels reached with HSP70B promoter alone and the prototypical human cytomegalovirus promoter. Conclusions: Thus, the inducible amplifier vector, pAD-HotAmp-GM-CSF, represents a novel system for regulated and enhanced GM-CSF expression, which enables both greater efficacy and safety in cytokine immunotherapy of cancer.
Journal of Experimental Therapeutics and Oncology | 2006
David T. Harris; Tom C. Tsang; Xianghui He; Brian L. Pipes; Linda C. Meade-Tollin
Annals of Clinical and Laboratory Science | 2006
Brian L. Pipes; Richard J. Ablin
Current Oncology | 2005
Richard J. Ablin; Brian L. Pipes
Archive | 2011
David T. Harris; Xianghui He; Linda C. Meade-Tollin; Brian L. Pipes; Tom C. Tsang; トム シー. ツアン; デビッド ティー. ハリス; シャンフイ ヒ; ブライアン エル. ピペス; リンダ シー. ミーデ―トリン
Archive | 2006
David T. Harris; Tom C. Tsang; Xianghui He; Brian L. Pipes; Linda C. Meade-Tollin
Archive | 2006
David T. Harris; Tom C. Tsang; Xianghui He; Brian L. Pipes; Linda C. Meade-Tollin